Introduction
The trade-off we're examining today is whether Chewy should prioritize expanding its prescription medication offerings to boost revenue or focus on improving delivery speed for its existing pet food products. This scenario touches on key aspects of Chewy's business model, including product diversification and operational efficiency. I'll analyze this trade-off by considering various factors such as market opportunity, customer needs, operational capabilities, and long-term strategic implications.
I'd like to start by asking a few clarifying questions to ensure we're aligned on the context and constraints of this decision. Then, I'll walk through a structured analysis framework to evaluate both options and provide a recommendation.
Step 1
Clarifying Questions (3 minutes)
Why it matters: Helps assess the revenue potential of expanding into medications Expected answer: Pet medication market growing faster than pet food Impact on approach: Higher growth would favor medication expansion
Why it matters: Determines the scope of improvement needed in delivery speed Expected answer: Current 3-5 days, aiming for 1-2 day delivery Impact on approach: Larger gap might prioritize delivery speed improvement
Why it matters: Indicates potential for cross-selling and customer retention Expected answer: 30-40% of customers buy medications elsewhere Impact on approach: High overlap would support medication expansion
Why it matters: Assesses the technical feasibility and resource requirements Expected answer: Basic system in place, needs significant development Impact on approach: Less developed system might delay medication expansion
Why it matters: Helps understand the potential impact on overall business model Expected answer: 70% from pet food, 30% from other products Impact on approach: Higher reliance on pet food might favor delivery speed improvement
Practice similar questions
Subscribe to access the full answer
.png){kind=logo}
